Hagerty, Inc. Form 8-K Summary
Business Context and Reporting Period
Hagerty, Inc. filed a Current Report on Form 8-K dated December 18, 2023, reporting amendments to its strategic alliance and subsidiary operating agreements with Markel Corporation. Markel is a significant stockholder holding more than 5% of Hagerty’s outstanding common stock and has the right to nominate one director.
Material Agreements and Key Changes
- Hagerty’s subsidiary, The Hagerty Group, LLC, entered into a Fifth Amended and Restated Master Alliance Agreement with Hagerty, Inc. and Markel.
- The agreement adds a definition of “Enthusiast Business” and removes that business from the definitions of “Restricted Business” and “Alliance Business.”
- Hagerty’s acquisition rights relating to Essentia Insurance Company were delayed until no earlier than 2026 and no later than 2030.
- Hagerty received a new waiver permitting it to pursue a strategic opportunity with a third-party insurance company.
- An amended agency agreement moved five points from contingent underwriting commission to base commission and changed contingent underwriting commission payments from annual to monthly.
- Hagerty, Markel, and the other members of The Hagerty Group, LLC entered into a Sixth Amended and Restated LLC Agreement, principally to align the definition of “Restricted Business” with the amended Alliance Agreement.
Financial Metrics and Liquidity
The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, balance-sheet, or other operating performance metrics. It also does not quantify the financial impact of the commission reallocation, the revised payment frequency, the delayed acquisition rights, or the third-party insurance opportunity.
Outlook, Risks, and Unusual Items
- The delayed Essentia acquisition timetable may affect the timing of any potential ownership or strategic benefits; the filing does not state whether the acquisition will occur.
- The new waiver expands Hagerty’s ability to pursue a third-party insurance opportunity, but no transaction terms, timing, financing, or expected financial impact are disclosed.
- The commission amendment changes the mix and timing of payments between base commission and contingent underwriting commission, which may affect revenue recognition or cash-flow timing; the filing does not quantify the effect.
- Portions of the Fifth Amended and Restated Master Alliance Agreement were omitted under Item 601(b)(10)(iv) of Regulation S-K and will be furnished to the SEC upon request.
Investor Verification Items
- Review Exhibits 10.1 and 10.2 for the complete rights, restrictions, waivers, acquisition provisions, and governance terms.
- Verify the economic effect of moving five commission points to base commission and changing contingent commission payments to monthly.
- Monitor developments regarding the potential Essentia acquisition between 2026 and 2030.
- Determine the scope, timing, and expected economics of any strategic opportunity with a third-party insurance company.
- Assess any related-party implications arising from Markel’s ownership interest and board nomination right.